Impact & STories
Featured
Gibson Oncology, NIH to begin Phase 2 trials of LMP744 for treatment of first-time recurrent glioblastoma
Study will evaluate tumor regression in approximately 40 cancer patients February 25, 2026 | Steve...
Pharmacy helps propel Purdue to No. 7 nationally for U.S. patents received
February 12, 2026 | Steve Martin WEST LAFAYETTE, Ind. — An innovation to detect heart rate,...
New master’s in radiopharmaceutical manufacturing gives students hands-on experience in growing field
February 11, 2026 | RM Barton WEST LAFAYETTE, Ind. — The field of theranostics, which involves...
All Stories
Gibson Oncology, NIH to begin Phase 2 trials of LMP744 for treatment of first-time recurrent glioblastoma
The Purdue University College of Pharmacy celebrated excellence in research and scholarship during its annual Research Day, highlighting the innovative work of graduate students...
Pharmacy helps propel Purdue to No. 7 nationally for U.S. patents received
The Purdue University College of Pharmacy celebrated excellence in research and scholarship during its annual Research Day, highlighting the innovative work of graduate students...
New master’s in radiopharmaceutical manufacturing gives students hands-on experience in growing field
The Purdue University College of Pharmacy celebrated excellence in research and scholarship during its annual Research Day, highlighting the innovative work of graduate students...
Purdue College of Pharmacy Celebrates Excellence at 2025 Research Day
The Purdue University College of Pharmacy celebrated excellence in research and scholarship during its annual Research Day, highlighting the innovative work of graduate students...
